Summary

The global ostomy dressings market is projected to reach USD 4.73 billion by 2031 from USD 3.80 billion in 2026, at a CAGR of 4.4% during the forecast period.

https://mnmimg.marketsandmarkets.com/Images/ostomy-dressings-market-img-overview.webp

The ostomy dressings market is projected to grow due to a rise in cases of colorectal cancer, inflammatory bowel diseases, and an aging population that requires ongoing care. Increased awareness of peristomal skin disorders, along with higher survival rates, also contribute to sustained industry growth. Additionally, improvements in healthcare infrastructure in developing countries, favorable reimbursement policies, and the availability of home care services are enhancing access to ostomy dressing products.
“By product, the skin barrier rings segment is projected to grow at the highest CAGR in the ostomy dressings market during the forecast period.”
The market for ostomy products is divided into several segments: ostomy bags/pouches, skin barrier sheets, skin barrier rings, film dressings, and other products. Among these, the skin barrier rings subsegment is expected to grow the fastest during the forecast period. This growth is driven by increasing awareness of peristomal skin issues and the rising demand for effective leakage protection. Skin barrier rings are moldable and adhesive aids used around the stoma site to create a seal between the skin and the ostomy bag. Patients’ preference for home care and convenience is driving a growing demand for user-friendly, custom-fit products. Additionally, advancements in skin-friendly materials and a heightened focus on preventative skincare measures are contributing to the market's expansion.
“By end user, the hospitals segment held the second-largest share of the ostomy dressings market in 2025.”
The ostomy dressings market is categorized by end users into hospitals, home care settings, ambulatory surgery centers, and other end users. In 2025, the hospitals segment is expected to hold the second-largest market share. This is primarily due to the crucial role hospitals play in both surgeries and post-surgery care. Most ostomy cases, including colostomy, ileostomy, and urostomy, typically occur in hospitals, making them a significant source of demand for ostomy dressings during treatment. Additionally, hospitals are important for educating patients about ostomy care and offering a variety of products for treatment. They employ highly skilled personnel who use advanced products, leading to an increased utilization of ostomy dressings within these facilities.
“The Asia Pacific regional segment is expected to grow at the highest CAGR in the ostomy dressings market during the forecast period.”
The ostomy dressings market is divided into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
The Asia Pacific market is expected to experience the highest CAGR due to the increasing burden of cancer in the region, which will lead to a rise in the number of patients requiring ostomy surgery. In 2022, India reported approximately 1.46 million newly diagnosed cancer cases (Indian Journal of Medical Research), while China estimated around 4.82 million cases (GLOBOCAN 2022). Moreover, Japan is projected to reach about 979,300 cases by 2024, according to an article published by the Foundation for the Promotion of Cancer Research. These figures highlight the significant need for surgeries, particularly for colorectal and bladder cancers.
Additionally, the Asia Pacific region is benefiting from advancements in healthcare infrastructure, increased healthcare spending, and improved access to surgical facilities. Growing awareness of ostomy care, supportive reimbursement policies, and home care initiatives are also contributing to the adoption of ostomy products.
A breakdown of the primary participants (supply side) for the ostomy dressings market referred to in this report is provided below:
? By Company Type: Tier 1 (35%), Tier 2 (40%), and Tier 3 (25%)
? By Designation: C-level Executives (45%), Directors (35%), and Others (20%)
? By Region: North America (27%), Europe (25%), Asia Pacific (30%), Latin America (8%), and the Middle East & Africa (10%)
Prominent players in the ostomy dressings market: Coloplast A/S (Denmark), ConvaTec Group Plc (UK), Hollister (US), Salts Healthcare (UK), B. Braun SE (Germany), Solventum (US), Welland Medical Limited (UK), ALCARE Co., Ltd. (Japan), Eakin Healthcare Group (Ireland), Marlen Manufacturing & Development (US), Advin Health Care (India), and Nu-Hope Laboratories, Inc. (US), among others

Research Coverage
The report analyzes the ostomy dressings market and estimates its size and future growth potential across segments such as product, application, end user, and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will help market leaders/new entrants in this market by providing information on the closest approximations of revenue for the overall ostomy dressing market. This report will help stakeholders understand the competitive landscape and gain deeper insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
? Analysis of key drivers (rising colorectal and bladder cancer incidence and rising IBD prevalence), restraints (post-surgical complications and quality-of-life concerns), opportunities (rising reimbursement support and awareness initiatives), and challenges (limited awareness and education among patients and caregivers)
? Market Penetration: It includes extensive information on products offered by the major players in the global ostomy dressings market. The report includes various segments in products, applications, end users, and regions.
? Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global ostomy dressings market.
? Market Development: Thorough knowledge and analysis of the profitable rising markets by product, application, end user, and region.
? Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global ostomy dressings market.
? Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global ostomy dressings market.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 24
1.1 STUDY OBJECTIVES 24
1.2 MARKET DEFINITION 24
1.3 STUDY SCOPE 25
1.3.1 MARKETS COVERED & REGIONAL SEGMENTATION 25
1.3.2 INCLUSIONS & EXCLUSIONS 26
1.3.3 YEARS CONSIDERED 27
1.3.4 CURRENCY CONSIDERED 27
1.4 STAKEHOLDERS 28
2 EXECUTIVE SUMMARY 29
2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 29
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND START DEVELOPMENTS 30
2.3 DISRUPTIVE TRENDS SHAPING MARKET 31
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 32
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 33
3 PREMIUM INSIGHTS 34
3.1 OSTOMY DRESSINGS MARKET OVERVIEW 34
3.2 NORTH AMERICA: OSTOMY DRESSINGS MARKET, BY END USER 35
3.3 OSTOMY DRESSINGS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 36
3.4 OSTOMY DRESSINGS MARKET: REGIONAL MIX 36
3.5 OSTOMY DRESSINGS MARKET: DEVELOPED COUNTRIES VS. EMERGING ECONOMIES 37
4 MARKET OVERVIEW 38
4.1 INTRODUCTION 38
4.2 MARKET DYNAMICS 38
4.2.1 DRIVERS 38
4.2.1.1 Rise in colorectal and bladder cancer incidence accelerates long-term demand for ostomy dressing products 38
4.2.1.2 Rise in IBD prevalence driving sustained demand for ostomy dressings products 39
4.2.2 RESTRAINTS 39
4.2.2.1 Post-surgical complications and quality-of-life concerns are restraining ostomy dressing adoption 39
4.2.3 OPPORTUNITIES 40
4.2.3.1 Increase in reimbursement support and awareness initiatives drive adoption in emerging markets 40
4.2.4 CHALLENGES 40
4.2.4.1 Limited awareness and education among patients and caregivers 40
4.3 UNMET NEEDS AND WHITE SPACES 41
4.3.1 UNMET NEEDS IN OSTOMY DRESSINGS MARKET 41
4.3.2 WHITE SPACE OPPORTUNITIES 41
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 41
4.4.1 INTERCONNECTED MARKETS 41
4.4.2 CROSS-SECTOR OPPORTUNITIES 42
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 42
5 INDUSTRY TRENDS 43
5.1 PORTER’S FIVE FORCES ANALYSIS 43
5.1.1 THREAT OF NEW ENTRANTS 44
5.1.2 THREAT OF SUBSTITUTES 44
5.1.3 BARGAINING POWER OF BUYERS 44
5.1.4 BARGAINING POWER OF SUPPLIERS 44
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 45
5.2 MACROECONOMIC OUTLOOK 45
5.2.1 INTRODUCTION 45
5.2.2 GDP TRENDS AND FORECAST 45
5.2.3 TRENDS IN STOMA CARE INDUSTRY 47
5.2.4 TRENDS IN GLOBAL WOUND CARE INDUSTRY 47
5.3 SUPPLY CHAIN ANALYSIS 47
5.4 VALUE CHAIN ANALYSIS 48
5.5 ECOSYSTEM ANALYSIS 50
5.6 PRICING ANALYSIS 51
5.6.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS FOR VARIOUS PRODUCTS 51
5.6.2 AVERAGE SELLING PRICE TREND, BY REGION 52
5.7 TRADE ANALYSIS 52
5.7.1 IMPORT SCENARIO (HS CODE 300691) 52
5.7.2 EXPORT DATA (HS CODE 300691) 53
5.8 KEY CONFERENCES AND EVENTS, 2026?2027 54
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 55
5.10 INVESTMENT AND FUNDING SCENARIO 56
5.11 IMPACT OF 2025 US TARIFFS - OSTOMY DRESSINGS MARKET 56
5.11.1 INTRODUCTION 56
5.11.2 KEY TARIFF RATES 57
5.11.3 PRICE IMPACT ANALYSIS 58
5.11.4 IMPACT ON COUNTRIES/REGIONS 58
5.11.4.1 North America 58
5.11.4.2 Europe 58
5.11.4.3 Asia Pacific 58
5.11.5 END-USE INDUSTRY IMPACT 59
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 60
6.1 KEY EMERGING TECHNOLOGIES 60
6.1.1 ADVANCED SKIN BARRIER TECHNOLOGIES 60
6.1.2 LEAK PREVENTION & FLEXIBLE ADHESIVE SYSTEMS 60
6.2 COMPLEMENTARY TECHNOLOGIES 60
6.2.1 DERMATOLOGY AND SKIN CARE TECHNOLOGIES 60
6.3 TECHNOLOGY/PRODUCT ROADMAP 61
6.3.1 SHORT-TERM (2025?2027) | FOUNDATION & EARLY COMMERCIALIZATION 61
6.3.2 MID-TERM (2027?2030) | EXPANSION & STANDARDIZATION 61
6.3.3 LONG-TERM (2030?2035+) | MASS COMMERCIALIZATION & DISRUPTION 62
6.4 PATENT ANALYSIS 62
6.4.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 63
6.5 FUTURE APPLICATIONS 64
6.5.1 SMART OSTOMY SYSTEMS AND DIGITAL SUPPORT 64
6.5.2 SUSTAINABLE AND ECO-FRIENDLY OSTOMY PRODUCTS 65
6.6 IMPACT OF AI/GEN AI ON OSTOMY DRESSINGS MARKET 65
6.6.1 TOP USE CASES AND MARKET POTENTIAL 65
6.7 BEST PRACTICES IN OSTOMY DRESSING PROCESSING 66
6.7.1 CASE STUDIES OF AI IMPLEMENTATION IN OSTOMY DRESSINGS MARKET 66
6.7.2 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT
ON MARKET PLAYERS 66
6.7.3 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN
OSTOMY DRESSINGS MARKET 66
7 SUSTAINABILITY AND REGULATORY LANDSCAPE 67
7.1 REGIONAL REGULATIONS AND COMPLIANCE 67
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67
7.1.2 INDUSTRY STANDARDS 69
7.2 SUSTAINABILITY INITIATIVES 69
7.2.1 CARBON IMPACT AND ECO-APPLICATIONS OF OSTOMY DRESSINGS MARKET 69
7.2.1.1 Carbon impact reduction 69
7.2.1.2 Eco-applications 70
7.3 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES 70
7.4 CERTIFICATIONS, LABELING, ECO-STANDARDS 70
7.5 REIMBURSEMENT ANALYSIS 71
?
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 72
8.1 DECISION-MAKING PROCESS 72
8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 72
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 72
8.2.2 KEY BUYING CRITERIA 73
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 74
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 74
8.5 MARKET PROFITABILITY 74
8.5.1 REVENUE POTENTIAL 75
8.5.2 COST DYNAMICS 75
8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS 75
9 OSTOMY DRESSINGS MARKET, BY PRODUCT 76
9.1 INTRODUCTION 77
9.2 BAGS/POUCHES 77
9.2.1 COLOSTOMY BAGS/POUCHES 78
9.2.1.1 Rise in colorectal cancer burden to drive sustained demand for colostomy bags 78
9.2.2 ILEOSTOMY BAGS/POUCHES 79
9.2.2.1 Rise in prevalence of inflammatory bowel diseases to fuel growth of ileostomy bags 79
9.2.3 UROSTOMY BAGS/POUCHES 81
9.2.3.1 Increase in bladder cancer incidence to support sustained demand for urostomy bags 81
9.3 SKIN BARRIER SHEETS 82
9.3.1 INCREASE IN FOCUS ON PERISTOMAL SKIN PROTECTION AND COMPLICATION PREVENTION TO FUEL GROWTH OF SKIN BARRIER SHEETS 82
9.4 SKIN BARRIER RINGS 83
9.4.1 RISE IN FOCUS ON LEAKAGE PREVENTION AND SKIN PROTECTION DRIVING GROWTH OF OSTOMY SKIN BARRIER RINGS 83
9.5 FILM DRESSINGS 84
9.5.1 GROWTH IN EMPHASIS ON PREVENTIVE SKIN CARE AND ADHESION SUPPORT TO SUPPORT ADOPTION OF OSTOMY FILM DRESSINGS 84
9.6 OTHER PRODUCTS 85
10 OSTOMY DRESSINGS MARKET, BY APPLICATION 86
10.1 INTRODUCTION 87
10.2 CANCER (COLON, BLADDER) 87
10.2.1 CONTINUOUS USAGE OF RELIABLE, HIGH-PERFORMANCE PRODUCTS ACROSS EXTENDED CANCER SURVIVAL PERIODS TO DRIVE CONSUMPTION VOLUMES 87
10.3 CROHN’S DISEASE 88
10.3.1 LIFELONG MANAGEMENT OF CROHN’S DISEASE WITH POTENTIAL FOR MULTIPLE SURGERIES INCREASES DEPENDENCY ON OSTOMY CARE SOLUTIONS 88
10.4 TRAUMATIC INJURY 90
10.4.1 DEPENDENCY ON OSTOMY DRESSINGS FOR POST-SURGICAL MANAGEMENT DURING RECOVERY OR LONG-TERM CARE TO DRIVE CONSISTENT DEMAND 90
10.5 ULCERATIVE COLITIS 91
10.5.1 CHRONIC NATURE OF UC, COMBINED WITH INCREASING INCIDENCE AND LONG-TERM DISEASE MANAGEMENT, TO DRIVE SUSTAINED DEMAND 91
10.6 OTHER APPLICATIONS 92
11 OSTOMY DRESSINGS MARKET, BY END USER 93
11.1 INTRODUCTION 94
11.2 HOME CARE SETTINGS 95
11.2.1 HOME CARE SETTINGS SEGMENT HELD MAJOR SHARE IN MARKET 95
11.3 HOSPITALS 96
11.3.1 HIGH VOLUME OF OSTOMY SURGERIES IN HOSPITALS TO DRIVE SIGNIFICANT DEMAND 96
11.4 AMBULATORY SURGICAL CENTERS 97
11.4.1 GROWTH IN COST-EFFICIENT OUTPATIENT COLORECTAL PROCEDURES TO DRIVE SEGMENTAL GROWTH 97
11.5 OTHER END USERS 98
12 OSTOMY DRESSINGS MARKET, BY REGION 99
12.1 INTRODUCTION 100
12.2 NORTH AMERICA 101
12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 101
12.2.2 US 103
12.2.2.1 US: Largest country-level North American market 103
12.2.3 CANADA 105
12.2.3.1 Rise in cancer burden and aging population to drive demand 105
12.3 EUROPE 107
12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 107
12.3.2 GERMANY 110
12.3.2.1 Germany: Largest share in European ostomy dressings market 110
12.3.3 UK 111
12.3.3.1 Established stoma patient base driving demand 111
12.3.4 FRANCE 113
12.3.4.1 High ostomy patient base and cancer incidence to fuel demand 113
12.3.5 ITALY 115
12.3.5.1 Rise in cancer incidence and established stoma patient base to drive ostomy dressing products demand 115
12.3.6 SPAIN 116
12.3.6.1 Increase in urostomy procedures to drive ostomy care demand in Spain 116
12.3.7 REST OF EUROPE 118
?
12.4 ASIA PACIFIC 120
12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 120
12.4.2 CHINA 123
12.4.2.1 China: Largest share in Asia Pacific ostomy dressings market 123
12.4.3 JAPAN 124
12.4.3.1 Rising disease burden, with advanced healthcare infrastructure, strong reimbursement systems, and high adoption of innovative medical products, in Japan 124
12.4.4 INDIA 126
12.4.4.1 Rise in cancer incidence and expanding access to surgical care to support demand 126
12.4.5 AUSTRALIA 128
12.4.5.1 Established patient base and strong healthcare infrastructure, reimbursement support through national programs to aid market growth 128
12.4.6 SOUTH KOREA 129
12.4.6.1 Increase in cancer incidence to aid growth of ostomy dressings market in South Korea 129
12.4.7 REST OF ASIA PACIFIC 131
12.5 LATIN AMERICA 133
12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 133
12.5.2 BRAZIL 135
12.5.2.1 Brazil: Largest share in Latin American market 135
12.5.3 MEXICO 137
12.5.3.1 Population prone to cancer and gastrointestinal disorders and aging to contribute to market growth 137
12.5.4 REST OF LATIN AMERICA 139
12.6 MIDDLE EAST & AFRICA 140
12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 140
12.6.2 GCC COUNTRIES 143
12.6.2.1 Rise in cancer incidence and strong healthcare infrastructure to aid market growth 143
12.6.3 REST OF MIDDLE EAST & AFRICA 144
13 COMPETITIVE LANDSCAPE 147
13.1 INTRODUCTION 147
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 147
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN OSTOMY DRESSINGS MARKET 147
13.3 REVENUE ANALYSIS, 2021?2025 148
13.4 MARKET SHARE ANALYSIS, 2025 149
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 151
13.5.1 STARS 151
13.5.2 PERVASIVE PLAYERS 151
13.5.3 EMERGING LEADERS 151
13.5.4 PARTICIPANTS 151
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 153
13.5.5.1 Company footprint 153
13.5.5.2 Regional footprint 154
13.5.5.3 Product Footprint 154
13.5.5.4 Application footprint 155
13.5.5.5 End-user footprint 155
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 156
13.6.1 PROGRESSIVE COMPANIES 156
13.6.2 RESPONSIVE COMPANIES 156
13.6.3 DYNAMIC COMPANIES 156
13.6.4 STARTING BLOCKS 156
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 158
13.6.5.1 Detailed list of key startups/SMEs 158
13.6.5.2 Competitive benchmarking of key startups/SMEs 159
13.7 COMPANY VALUATION & FINANCIAL METRICS 160
13.7.1 FINANCIAL METRICS 160
13.7.2 COMPANY VALUATION 160
13.8 BRAND/PRODUCT COMPARISON 161
13.9 COMPETITIVE SCENARIO 162
13.9.1 PRODUCT LAUNCHES & APPROVALS 162
13.9.2 DEALS 163
13.9.3 EXPANSIONS 164
14 COMPANY PROFILES 165
14.1 KEY PLAYERS 165
14.1.1 COLOPLAST A/S 165
14.1.1.1 Business overview 165
14.1.1.2 Products offered 166
14.1.1.3 Recent developments 170
14.1.1.3.1 Product launches & approvals 170
14.1.1.3.2 Deals 170
14.1.1.3.3 Expansions 170
14.1.1.4 MnM view 171
14.1.1.4.1 Right to win 171
14.1.1.4.2 Strategic choices 171
14.1.1.4.3 Weaknesses & competitive threats 171
14.1.2 CONVATEC GROUP PLC 172
14.1.2.1 Business overview 172
14.1.2.2 Products offered 173
14.1.2.3 Recent developments 176
14.1.2.3.1 Product launches & approvals 176
14.1.2.3.2 Deals 176
14.1.2.3.3 Expansions 176
14.1.2.4 MnM view 177
14.1.2.4.1 Right to win 177
14.1.2.4.2 Strategic choices 177
14.1.2.4.3 Weaknesses & competitive threats 177
14.1.3 B BRAUN SE 178
14.1.3.1 Business overview 178
14.1.3.2 Products offered 179
14.1.3.3 MnM view 181
14.1.3.3.1 Right to win 181
14.1.3.3.2 Strategic choices 181
14.1.3.3.3 Weaknesses & competitive threats 181
14.1.4 HOLLISTER INCORPORATED 182
14.1.4.1 Business overview 182
14.1.4.2 Recent developments 185
14.1.4.2.1 Product launches & approvals 185
14.1.4.2.2 Expansions 185
14.1.4.2.3 Other developments 185
14.1.4.3 MnM view 186
14.1.4.3.1 Right to win 186
14.1.4.3.2 Strategic choices 186
14.1.4.3.3 Weaknesses & competitive threats 186
14.1.5 SOLVENTUM 187
14.1.5.1 Business overview 187
14.1.5.2 Recent developments 189
14.1.5.2.1 Other developments 189
14.1.5.3 MnM view 189
14.1.5.3.1 Right to win 189
14.1.5.3.2 Strategic choices 189
14.1.5.3.3 Weaknesses & competitive threats 189
14.1.6 ADVIN HEALTH CARE 190
14.1.6.1 Business overview 190
14.1.6.2 Recent developments 191
14.1.6.2.1 Expansions 191
14.1.7 SALTS HEALTHCARE 192
14.1.7.1 Business overview 192
14.1.8 WELLAND MEDICAL LIMITED 194
14.1.8.1 Business overview 194
14.1.8.2 Recent developments 195
14.1.8.2.1 Product launches & approvals 195
14.1.8.2.2 Deals 196
14.1.9 ALCARE CO., LTD. 197
14.1.9.1 Business overview 197
14.1.10 EAKIN 199
14.1.10.1 Business overview 199
14.1.10.1.1 Expansions 201
14.1.11 MARLEN MANUFACTURING & DEVELOPMENT COMPANY 202
14.1.11.1 Business overview 202
14.2 OTHER PLAYERS 204
14.2.1 CYMED 204
14.2.2 ADVACARE PHARMA 205
14.2.3 NU-HOPE LABORATORIES, INC. 206
14.2.4 SAFE N SIMPLE LLC 207
14.2.5 TORBOT, A DIVISION OF SAFETEC 208
14.2.6 FOR LIFE PRODUKTIONS 209
14.2.7 FORTIS MEDICAL PRODUCTS 210
14.2.8 ANGIPLAST PRIVATE LIMITED 211
14.2.9 PROWESS CARE 211
14.2.10 TRIO HEALTHCARE LTD 212
14.2.11 AVITR FARMICA PVT LTD. 213
14.2.12 CRIMSON HEALTHCARE PVT. LTD 214
14.2.13 WUJIANG EVERGREEN EX/IM CO., LTD. 215
14.2.14 OSTOFORM 216
15 RESEARCH METHODOLOGY 217
15.1 RESEARCH DATA 217
15.1.1 SECONDARY DATA 217
15.1.1.1 Key data from secondary sources 219
15.1.2 PRIMARY DATA 219
15.1.2.1 Key data from primary sources 221
15.1.2.2 Key industry insights 221
15.2 MARKET SIZE ESTIMATION 222
15.3 DATA TRIANGULATION 227
15.4 MARKET RANKING ANALYSIS 228
15.5 STUDY ASSUMPTIONS 228
15.6 RESEARCH LIMITATIONS 228
15.6.1 METHODOLOGY-RELATED LIMITATIONS 228
15.6.2 SCOPE-RELATED LIMITATIONS 229
15.7 RISK ASSESSMENT 229
?
16 APPENDIX 230
16.1 DISCUSSION GUIDE 230
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 235
16.3 CUSTOMIZATION OPTIONS 237
16.4 RELATED REPORTS 237
16.5 AUTHOR DETAILS 238

ページTOPに戻る

List of Tables/Graphs

TABLE 1 OSTOMY DRESSINGS MARKET: INCLUSIONS & EXCLUSIONS 26
TABLE 2 STANDARD CURRENCY CONVERSION RATES 28
TABLE 3 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 42
TABLE 4 OSTOMY DRESSINGS MARKET: PORTER’S FIVE FORCES ANALYSIS 44
TABLE 5 GDP PERCENTAGE CHANGE, BY KEY COUNTRY, 2021?2030 45
TABLE 6 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT,
2023?2025 (USD) 51
TABLE 7 AVERAGE PRICING TREND OF OSTOMY DRESSING, BY REGION, 2023?2025 (USD) 52
TABLE 8 IMPORT DATA FOR OSTOMY DRESSING UNDER HS CODE 300691, BY COUNTRY, 2019?2024 (USD THOUSAND) 53
TABLE 9 EXPORT DATA FOR OSTOMY DRESSING UNDER HS CODE 300691, BY COUNTRY, 2019?2024 (USD THOUSAND) 53
TABLE 10 OSTOMY DRESSINGS MARKET: DETAILED LIST OF KEY CONFERENCES
AND EVENTS, 2026?2027 54
TABLE 11 US-ADJUSTED RECIPROCAL TARIFF RATES 57
TABLE 12 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR OSTOMY DRESSING PRODUCTS 58
TABLE 13 SMART OSTOMY SYSTEMS AND DIGITAL SUPPORT 64
TABLE 14 SUSTAINABLE AND ECO-FRIENDLY OSTOMY PRODUCTS 65
TABLE 15 TOP USE CASES AND MARKET POTENTIAL 65
TABLE 16 OSTOMY DRESSINGS MARKET: CASE STUDIES RELATED TO AI IMPLEMENTATION 66
TABLE 17 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 66
TABLE 18 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 67
TABLE 19 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 67
TABLE 20 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 68
TABLE 21 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 68
TABLE 22 MIDDLE EAST & AFRICA AND GCC COUNTRIES: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69
TABLE 23 GLOBAL STANDARDS IN OSTOMY DRESSINGS MARKET 69
TABLE 24 CERTIFICATIONS, LABELING, ECO-STANDARDS IN OSTOMY DRESSINGS MARKET 70
TABLE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR
OSTOMY DRESSING PRODUCTS 73
TABLE 26 KEY BUYING CRITERIA FOR TOP THREE OSTOMY DRESSING PRODUCTS 73
TABLE 27 OSTOMY DRESSINGS MARKET: UNMET NEEDS/END-USER EXPECTATIONS 74
TABLE 28 OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024?2031 (USD MILLION) 77
TABLE 29 OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024?2031 (USD MILLION) 78
TABLE 30 COLOSTOMY BAGS/POUCHES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 79
TABLE 31 ILEOSTOMY BAGS/POUCHES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 80
TABLE 32 UROSTOMY BAGS/POUCHES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 81
TABLE 33 OSTOMY SKIN BARRIER SHEETS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 82
TABLE 34 OSTOMY SKIN BARRIER RINGS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 83
TABLE 35 OSTOMY FILM DRESSINGS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 84
TABLE 36 OTHER OSTOMY DRESSING PRODUCTS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 85
TABLE 37 OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 87
TABLE 38 OSTOMY DRESSINGS MARKET IN CANCER TREATMENT, BY COUNTRY,
2024?2031 (USD MILLION) 88
TABLE 39 OSTOMY DRESSINGS MARKET IN CROHN’S DISEASE TREATMENT,
BY COUNTRY, 2024?2031 (USD MILLION) 89
TABLE 40 OSTOMY DRESSINGS MARKET IN TRAUMATIC INJURY TREATMENT,
BY COUNTRY, 2024?2031 (USD MILLION) 90
TABLE 41 OSTOMY DRESSINGS MARKET IN ULCERATIVE COLITIS TREATMENT,
BY COUNTRY, 2024?2031 (USD MILLION) 91
TABLE 42 OSTOMY DRESSINGS MARKET IN OTHER APPLICATIONS, BY COUNTRY,
2024?2031 (USD MILLION) 92
TABLE 43 OSTOMY DRESSINGS MARKET, BY END USER, 2024?2031 (USD MILLION) 94
TABLE 44 OSTOMY DRESSINGS MARKET FOR HOME CARE SETTINGS, BY COUNTRY,
2024?2031 (USD MILLION) 95
TABLE 45 OSTOMY DRESSINGS MARKET FOR HOSPITALS, BY COUNTRY,
2024?2031 (USD MILLION) 96
TABLE 46 OSTOMY DRESSINGS MARKET FOR AMBULATORY SURGICAL CENTERS,
BY COUNTRY, 2024?2031 (USD MILLION) 97
TABLE 47 OSTOMY DRESSINGS MARKET FOR OTHER END USERS, BY COUNTRY,
2024?2031 (USD MILLION) 98
TABLE 48 OSTOMY DRESSINGS MARKET, BY REGION, 2024?2031 (USD MILLION) 101
TABLE 49 NORTH AMERICA: OSTOMY DRESSINGS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 101
TABLE 50 NORTH AMERICA: OSTOMY DRESSINGS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 102
TABLE 51 NORTH AMERICA: OSTOMY DRESSINGS MARKET, BY PRODUCT,
2024?2031 (THOUSAND UNITS) 102
TABLE 52 NORTH AMERICA: OSTOMY BAGS/POUCHES MARKET, BY TYPE,
2024?2031 (USD MILLION) 102
TABLE 53 NORTH AMERICA: OSTOMY DRESSINGS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 103
TABLE 54 NORTH AMERICA: OSTOMY DRESSINGS MARKET, BY END USER,
2024?2031 (USD MILLION) 103
TABLE 55 US: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024?2031 (USD MILLION) 104
TABLE 56 US: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024?2031 (USD MILLION) 104
TABLE 57 US: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 104
TABLE 58 US: OSTOMY DRESSINGS MARKET, BY END USER, 2024?2031 (USD MILLION) 105
TABLE 59 CANADA: OSTOMY DRESSINGS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 105
TABLE 60 CANADA: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024?2031 (USD MILLION) 106
TABLE 61 CANADA: OSTOMY DRESSINGS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 106
TABLE 62 CANADA: OSTOMY DRESSINGS MARKET, BY END USER,
2024?2031 (USD MILLION) 106
TABLE 63 EUROPE: OSTOMY DRESSINGS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 108
TABLE 64 EUROPE: OSTOMY DRESSINGS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 108
TABLE 65 EUROPE: OSTOMY DRESSINGS MARKET, BY PRODUCT,
2024?2031 (THOUSAND UNITS) 108
TABLE 66 EUROPE: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024?2031 (USD MILLION) 109
TABLE 67 EUROPE: OSTOMY DRESSINGS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 109
TABLE 68 EUROPE: OSTOMY DRESSINGS MARKET, BY END USER,
2024?2031 (USD MILLION) 109
TABLE 69 GERMANY: OSTOMY DRESSINGS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 110
TABLE 70 GERMANY: OSTOMY BAGS/POUCHES MARKET, BY TYPE,
2024?2031 (USD MILLION) 110
TABLE 71 GERMANY: OSTOMY DRESSINGS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 111
TABLE 72 GERMANY: OSTOMY DRESSINGS MARKET, BY END USER,
2024?2031 (USD MILLION) 111
TABLE 73 UK: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024?2031 (USD MILLION) 112
TABLE 74 UK: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024?2031 (USD MILLION) 112
TABLE 75 UK: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 112
TABLE 76 UK: OSTOMY DRESSINGS MARKET, BY END USER, 2024?2031 (USD MILLION) 113
TABLE 77 FRANCE: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024?2031 (USD MILLION) 113
TABLE 78 FRANCE: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024?2031 (USD MILLION) 114
TABLE 79 FRANCE: OSTOMY DRESSINGS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 114
TABLE 80 FRANCE: OSTOMY DRESSINGS MARKET, BY END USER,
2024?2031 (USD MILLION) 114
TABLE 81 ITALY: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024?2031 (USD MILLION) 115
TABLE 82 ITALY: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024?2031 (USD MILLION) 115
TABLE 83 ITALY: OSTOMY DRESSINGS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 116
TABLE 84 ITALY: OSTOMY DRESSINGS MARKET, BY END USER, 2024?2031 (USD MILLION) 116
TABLE 85 SPAIN: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024?2031 (USD MILLION) 117
TABLE 86 SPAIN: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024?2031 (USD MILLION) 117
TABLE 87 SPAIN: OSTOMY DRESSINGS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 117
TABLE 88 SPAIN: OSTOMY DRESSINGS MARKET, BY END USER, 2024?2031 (USD MILLION) 118
TABLE 89 REST OF EUROPE: OSTOMY DRESSINGS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 118
TABLE 90 REST OF EUROPE: OSTOMY BAGS/POUCHES MARKET, BY TYPE,
2024?2031 (USD MILLION) 119
TABLE 91 REST OF EUROPE: OSTOMY DRESSINGS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 119
TABLE 92 REST OF EUROPE: OSTOMY DRESSINGS MARKET, BY END USER,
2024?2031 (USD MILLION) 119
TABLE 93 ASIA PACIFIC: OSTOMY DRESSINGS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 121
TABLE 94 ASIA PACIFIC: OSTOMY DRESSINGS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 121
TABLE 95 ASIA PACIFIC: OSTOMY DRESSINGS MARKET, BY PRODUCT,
2024?2031 (THOUSAND UNITS) 121
TABLE 96 ASIA PACIFIC: OSTOMY BAGS/POUCHES MARKET, BY TYPE,
2024?2031 (USD MILLION) 122
TABLE 97 ASIA PACIFIC: OSTOMY DRESSINGS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 122
TABLE 98 ASIA PACIFIC: OSTOMY DRESSINGS MARKET, BY END USER,
2024?2031 (USD MILLION) 122
TABLE 99 CHINA: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024?2031 (USD MILLION) 123
TABLE 100 CHINA: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024?2031 (USD MILLION) 123
TABLE 101 CHINA: OSTOMY DRESSINGS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 124
TABLE 102 CHINA: OSTOMY DRESSINGS MARKET, BY END USER, 2024?2031 (USD MILLION) 124
TABLE 103 JAPAN: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024?2031 (USD MILLION) 125
TABLE 104 JAPAN: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024?2031 (USD MILLION) 125
TABLE 105 JAPAN: OSTOMY DRESSINGS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 125
TABLE 106 JAPAN: OSTOMY DRESSINGS MARKET, BY END USER, 2024?2031 (USD MILLION) 126
TABLE 107 INDIA: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024?2031 (USD MILLION) 126
TABLE 108 INDIA: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024?2031 (USD MILLION) 127
TABLE 109 INDIA: OSTOMY DRESSINGS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 127
TABLE 110 INDIA: OSTOMY DRESSINGS MARKET, BY END USER, 2024?2031 (USD MILLION) 127
TABLE 111 AUSTRALIA: OSTOMY DRESSINGS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 128
TABLE 112 AUSTRALIA: OSTOMY BAGS/POUCHES MARKET, BY TYPE,
2024?2031 (USD MILLION) 128
TABLE 113 AUSTRALIA: OSTOMY DRESSINGS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 129
TABLE 114 AUSTRALIA: OSTOMY DRESSINGS MARKET, BY END USER,
2024?2031 (USD MILLION) 129
TABLE 115 SOUTH KOREA: OSTOMY DRESSINGS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 130
TABLE 116 SOUTH KOREA: OSTOMY BAGS/POUCHES MARKET, BY TYPE,
2024?2031 (USD MILLION) 130
TABLE 117 SOUTH KOREA: OSTOMY DRESSINGS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 130
TABLE 118 SOUTH KOREA: OSTOMY DRESSINGS MARKET, BY END USER,
2024?2031 (USD MILLION) 131
TABLE 119 REST OF ASIA PACIFIC: OSTOMY DRESSINGS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 131
TABLE 120 REST OF ASIA PACIFIC: OSTOMY BAGS/POUCHES MARKET, BY TYPE,
2024?2031 (USD MILLION) 132
TABLE 121 REST OF ASIA PACIFIC: OSTOMY DRESSINGS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 132
TABLE 122 REST OF ASIA PACIFIC: OSTOMY DRESSINGS MARKET, BY END USER,
2024?2031 (USD MILLION) 132
TABLE 123 LATIN AMERICA: OSTOMY DRESSINGS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 133
TABLE 124 LATIN AMERICA: OSTOMY DRESSINGS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 134
TABLE 125 LATIN AMERICA: OSTOMY DRESSINGS MARKET, BY PRODUCT,
2024?2031 (THOUSAND UNITS) 134
TABLE 126 LATIN AMERICA: OSTOMY BAGS/POUCHES MARKET, BY TYPE,
2024?2031 (USD MILLION) 134
TABLE 127 LATIN AMERICA: OSTOMY DRESSINGS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 135
TABLE 128 LATIN AMERICA: OSTOMY DRESSINGS MARKET, BY END USER,
2024?2031 (USD MILLION) 135
TABLE 129 BRAZIL: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024?2031 (USD MILLION) 136
TABLE 130 BRAZIL: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024?2031 (USD MILLION) 136
TABLE 131 BRAZIL: OSTOMY DRESSINGS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 136
TABLE 132 BRAZIL: OSTOMY DRESSINGS MARKET, BY END USER, 2024?2031 (USD MILLION) 137
TABLE 133 MEXICO: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024?2031 (USD MILLION) 137
TABLE 134 MEXICO: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024?2031 (USD MILLION) 138
TABLE 135 MEXICO: OSTOMY DRESSINGS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 138
TABLE 136 MEXICO: OSTOMY DRESSINGS MARKET, BY END USER,
2024?2031 (USD MILLION) 138
TABLE 137 REST OF LATIN AMERICA: OSTOMY DRESSINGS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 139
TABLE 138 REST OF LATIN AMERICA: OSTOMY BAGS/POUCHES MARKET, BY TYPE,
2024?2031 (USD MILLION) 139
TABLE 139 REST OF LATIN AMERICA: OSTOMY DRESSINGS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 140
TABLE 140 REST OF LATIN AMERICA: OSTOMY DRESSINGS MARKET, BY END USER,
2024?2031 (USD MILLION) 140
TABLE 141 MIDDLE EAST & AFRICA: OSTOMY DRESSINGS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 141
TABLE 142 MIDDLE EAST & AFRICA: OSTOMY DRESSINGS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 141
TABLE 143 MIDDLE EAST & AFRICA: OSTOMY DRESSINGS MARKET, BY PRODUCT,
2024?2031 (THOUSAND UNITS) 141
TABLE 144 MIDDLE EAST & AFRICA: OSTOMY BAGS/POUCHES MARKET, BY TYPE,
2024?2031 (USD MILLION) 142
TABLE 145 MIDDLE EAST & AFRICA: OSTOMY DRESSINGS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 142
TABLE 146 MIDDLE EAST & AFRICA: OSTOMY DRESSINGS MARKET, BY END USER,
2024?2031 (USD MILLION) 142
TABLE 147 GCC COUNTRIES: OSTOMY DRESSINGS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 143
TABLE 148 GCC COUNTRIES: OSTOMY BAGS/POUCHES MARKET, BY TYPE,
2024?2031 (USD MILLION) 143
TABLE 149 GCC COUNTRIES: OSTOMY DRESSINGS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 144
TABLE 150 GCC COUNTRIES: OSTOMY DRESSINGS MARKET, BY END USER,
2024?2031 (USD MILLION) 144
TABLE 151 REST OF MIDDLE EAST & AFRICA: OSTOMY DRESSINGS MARKET,
BY PRODUCT, 2024?2031 (USD MILLION) 145
TABLE 152 REST OF MIDDLE EAST & AFRICA: OSTOMY BAGS/POUCHES MARKET,
BY TYPE, 2024?2031 (USD MILLION) 145
TABLE 153 REST OF MIDDLE EAST & AFRICA: OSTOMY DRESSINGS MARKET,
BY APPLICATION, 2024?2031 (USD MILLION) 145
TABLE 154 REST OF MIDDLE EAST & AFRICA: OSTOMY DRESSINGS MARKET,
BY END USER, 2024?2031 (USD MILLION) 146
TABLE 155 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN
OSTOMY DRESSINGS MARKET 147
TABLE 156 OSTOMY DRESSINGS MARKET: DEGREE OF COMPETITION 150
TABLE 157 OSTOMY DRESSINGS MARKET: REGIONAL FOOTPRINT, 2025 154
TABLE 158 OSTOMY DRESSINGS MARKET: PRODUCT FOOTPRINT, 2025 154
TABLE 159 OSTOMY DRESSINGS MARKET: APPLICATION FOOTPRINT, 2025 155
TABLE 160 OSTOMY DRESSINGS MARKET: END-USER FOOTPRINT, 2025 155
TABLE 161 OSTOMY DRESSINGS MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2025 158
TABLE 162 OSTOMY DRESSINGS MARKET: COMPETITIVE BENCHMARKING
OF KEY STARTUPS/SMES, 2025 159
TABLE 163 OSTOMY DRESSINGS MARKET: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022?MARCH 2026 162
TABLE 164 OSTOMY DRESSINGS MARKET: DEALS, JANUARY 2022?MARCH 2026 163
TABLE 165 OSTOMY DRESSINGS MARKET: EXPANSIONS, JANUARY 2022?MARCH 2026 164
TABLE 166 COLOPLAST A/S: COMPANY OVERVIEW 165
TABLE 167 COLOPLAST A/S: PRODUCTS OFFERED 166
TABLE 168 COLOPLAST A/S: PRODUCT LAUNCHES & APPROVALS 170
TABLE 169 COLOPLAST A/S: DEALS 170
TABLE 170 COLOPLAST A/S: EXPANSIONS 170
TABLE 171 CONVATEC GROUP PLC: COMPANY OVERVIEW 172
TABLE 172 CONVATEC GROUP PLC: PRODUCTS OFFERED 173
TABLE 173 CONVATEC GROUP PLC: PRODUCT LAUNCHES & APPROVALS 176
TABLE 174 CONVATEC GROUP PLC: DEALS 176
TABLE 175 CONVATEC GROUP PLC: EXPANSIONS 176
TABLE 176 B BRAUN SE: COMPANY OVERVIEW 178
TABLE 177 B BRAUN SE: PRODUCTS OFFERED 179
TABLE 178 HOLLISTER INCORPORATED: COMPANY OVERVIEW 182
TABLE 179 HOLLISTER INCORPORATED: PRODUCTS OFFERED 182
TABLE 180 HOLLISTER INCORPORATED: PRODUCT LAUNCHES & APPROVALS 185
TABLE 181 HOLLISTER INCORPORATED: EXPANSIONS 185
TABLE 182 HOLLISTER INCORPORATED: OTHER DEVELOPMENTS 185
TABLE 183 SOLVENTUM: COMPANY OVERVIEW 187
TABLE 184 SOLVENTUM: PRODUCTS OFFERED 188
TABLE 185 SOLVENTUM: OTHER DEVELOPMENTS 189
TABLE 186 ADVIN HEALTH CARE: COMPANY OVERVIEW 190
TABLE 187 ADVIN HEALTH CARE: PRODUCTS OFFERED 190
TABLE 188 ADVIN HEALTH CARE: EXPANSIONS 191
TABLE 189 SALTS HEALTHCARE: COMPANY OVERVIEW 192
TABLE 190 SALTS HEALTHCARE: PRODUCTS OFFERED 192
TABLE 191 WELLAND MEDICAL LIMITED: COMPANY OVERVIEW 194
TABLE 192 WELLAND MEDICAL LIMITED.: PRODUCTS OFFERED 194
TABLE 193 WELLAND MEDICAL LIMITED: PRODUCT LAUNCHES & APPROVALS 195
TABLE 194 WELLAND MEDICAL LIMITED: DEALS 196
TABLE 195 ALCARE CO., LTD.: COMPANY OVERVIEW 197
TABLE 196 ALCARE CO., LTD.: PRODUCTS OFFERED 197
TABLE 197 EAKIN: COMPANY OVERVIEW 199
TABLE 198 EAKIN: PRODUCTS OFFERED 199
TABLE 199 EAKIN: EXPANSIONS 201
TABLE 200 MARLEN MANUFACTURING & DEVELOPMENT COMPANY: COMPANY OVERVIEW 202
TABLE 201 MARLEN MANUFACTURING & DEVELOPMENT COMPANY: PRODUCTS OFFERED 202
TABLE 202 CYMED: COMPANY OVERVIEW 204
TABLE 203 ADVACARE PHARMA: COMPANY OVERVIEW 205
TABLE 204 NU-HOPE LABORATORIES, INC.: COMPANY OVERVIEW 206
TABLE 205 SAFE N SIMPLE LLC: COMPANY OVERVIEW 207
TABLE 206 TORBOT, A DIVISION OF SAFETEC: COMPANY OVERVIEW 208
TABLE 207 FOR LIFE PRODUKTIONS: COMPANY OVERVIEW 209
TABLE 208 FORTIS MEDICAL PRODUCTS: COMPANY OVERVIEW 210
TABLE 209 ANGIPLAST PRIVATE LIMITED: COMPANY OVERVIEW 211
TABLE 210 PROWESS CARE: COMPANY OVERVIEW 211
TABLE 211 TRIO HEALTHCARE LTD: COMPANY OVERVIEW 212
TABLE 212 AVITR FARMICA PVT LTD.: COMPANY OVERVIEW 213
TABLE 213 CRIMSON HEALTHCARE PVT. LTD: COMPANY OVERVIEW 214
TABLE 214 WUJIANG EVERGREEN EX/IM CO., LTD.: COMPANY OVERVIEW 215
TABLE 215 OSTOFORM: COMPANY OVERVIEW 216
TABLE 216 OSTOMY DRESSINGS MARKET: STUDY ASSUMPTIONS 228
TABLE 217 OSTOMY DRESSINGS MARKET: RISK ASSESSMENT ANALYSIS 229FIGURE 1 OSTOMY DRESSINGS MARKET: SEGMENTS CONSIDERED 25
FIGURE 2 YEARS CONSIDERED 27
FIGURE 3 KEY INSIGHTS AND MARKET HIGHLIGHTS 29
FIGURE 4 OSTOMY DRESSINGS MARKET, 2026?2031 (USD MILLION) 29
FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN OSTOMY DRESSINGS MARKET 30
FIGURE 6 DISRUPTIVE TRENDS IMPACTING GROWTH OF OSTOMY DRESSINGS MARKET 31
FIGURE 7 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS IN
OSTOMY DRESSINGS MARKET, 2025 32
FIGURE 8 EUROPE TO ACCOUNT FOR LARGEST MARKET SHARE DURING STUDY PERIOD 33
FIGURE 9 RISING PREVALENCE OF CANCER TO DRIVE MARKET GROWTH 34
FIGURE 10 HOME CARE SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN OSTOMY DRESSINGS MARKET IN 2025 35
FIGURE 11 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 36
FIGURE 12 EUROPE ACCOUNTED FOR LARGEST MARKET SHARE IN 2025 36
FIGURE 13 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH
RATES DURING FORECAST PERIOD 37
FIGURE 14 OSTOMY DRESSINGS MARKET: DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES 38
FIGURE 15 OSTOMY DRESSINGS MARKET: PORTER’S FIVE FORCES ANALYSIS 43
FIGURE 16 OSTOMY DRESSINGS MARKET: SUPPLY CHAIN ANALYSIS 48
FIGURE 17 OSTOMY DRESSINGS MARKET: VALUE CHAIN ANALYSIS 49
FIGURE 18 OSTOMY DRESSINGS MARKET: ECOSYSTEM ANALYSIS 50
FIGURE 19 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 55
FIGURE 20 OSTOMY DRESSINGS MARKET: INVESTMENT & FUNDING SCENARIO 56
FIGURE 21 NUMBER OF PATENTS PUBLISHED, JANUARY 2015?APRIL 2026 63
FIGURE 22 TOP APPLICANT COUNTRIES/REGIONS FOR OSTOMY PRODUCTS, JANUARY 2015? OCTOBER 2025 (NUMBER OF PATENTS) 64
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
FOR OSTOMY DRESSING PRODUCTS 72
FIGURE 24 KEY BUYING CRITERIA FOR TOP THREE OSTOMY DRESSING PRODUCTS 73
FIGURE 25 OSTOMY DRESSINGS MARKET: GEOGRAPHIC SNAPSHOT 100
FIGURE 26 EUROPE: OSTOMY DRESSINGS MARKET SNAPSHOT 107
FIGURE 27 ASIA PACIFIC: OSTOMY DRESSINGS MARKET SNAPSHOT 120
FIGURE 28 REVENUE ANALYSIS OF KEY PLAYERS IN OSTOMY DRESSINGS MARKET,
2021?2025 (USD MILLION) 148
FIGURE 29 MARKET SHARE ANALYSIS OF KEY PLAYERS IN OSTOMY
DRESSINGS MARKET (2025) 149
FIGURE 30 OSTOMY DRESSINGS MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2025 152
FIGURE 31 OSTOMY DRESSINGS MARKET: COMPANY FOOTPRINT, 2025 153
FIGURE 32 OSTOMY DRESSINGS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 157
FIGURE 33 EV/EBITDA OF KEY VENDORS, 2026 160
FIGURE 34 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDORS, 2026 160
FIGURE 35 OSTOMY DRESSINGS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 161
FIGURE 36 COLOPLAST A/S: COMPANY SNAPSHOT, 2025 166
FIGURE 37 CONVATEC GROUP PLC: COMPANY SNAPSHOT, 2025 173
FIGURE 38 B BRAUN SE: COMPANY SNAPSHOT, 2024 179
FIGURE 39 SOLVENTUM: COMPANY SNAPSHOT, 2025 188
FIGURE 40 RESEARCH DESIGN 217
FIGURE 41 PRIMARY SOURCES 220
FIGURE 42 PRIMARY BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 222
FIGURE 43 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS 223
FIGURE 44 TOP-DOWN APPROACH 223
FIGURE 45 BOTTOM-UP APPROACH 224
FIGURE 46 IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES, 2026?2031 225
FIGURE 47 OSTOMY DRESSINGS MARKET: CAGR PROJECTIONS 226
FIGURE 48 DATA TRIANGULATION METHODOLOGY 227